A Comprehensive Multiomics Analysis Identified Ubiquilin 4 as a Promising Prognostic Biomarker of Immune-Related Therapy in Pan-Cancer

In conclusion, UBQLN4 was a promising prognostic biomarker of immune-related therapy in pan-cancer.PMID:34539785 | PMC:PMC8443395 | DOI:10.1155/2021/7404927

Source: Journal of Oncology - September 20, 2021 Category: Cancer & Oncology Authors: Jie Li Ye Tong Zhi Wang Yi Liu Xiaobo Dai Yuxi Zhu Source Type: research